Notice: This company has been marked as potentially delisted and may not be actively trading. NYSE:ARPI (ARPI) (ARPI) Stock Price, News & Analysis Add Share Share Stock Analysis Stock Analysis About (ARPI) Stock (NYSE:ARPI) 30 days 90 days 365 days Advanced Chart Get (ARPI) alerts:Sign Up Key Stats Today's Range$15.89▼$15.8950-Day Range N/A52-Week Range$14.64▼$19.68VolumeN/AAverage Volume491,792 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAmerican Residential Properties, Inc. is an internally managed real estate investment company, which is organized as a real estate investment trust. The Company acquires, owns, renovates, and manages single-family homes as rental properties. American Residential Properties OP, L.P. acts as its operating partnership. American Residential Leasing Company, LLC is a wholly owned subsidiary of its operating partnership. The Company owns 8,893 properties in Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana, Nevada, North Carolina, Ohio, South Carolina, Tennessee and Texas that were 81% leased, and it managed an additional 437 properties for ARP Phoenix Fund I, LP in Arizona and Nevada. In addition to its primary business, the Company has a private mortgage financing business.Read More… Receive ARPI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (ARPI) and its competitors with MarketBeat's FREE daily newsletter. Email Address ARPI Stock News HeadlinesTalazoparib-Enzalutamide Improves Survival in Metastatic CRPCFebruary 16, 2025 | msn.comAdding Radioligand to Enzalutamide Boosts OS in Metastatic CRPCFebruary 14, 2025 | msn.com(1) Elon Musk’s Final Project REVEALEDThe world’s richest man has an ace up his sleeve. You see, while everyone is talking about Elon Musk’s plans to overhaul the federal government with President Trump… I want to tell you about his REAL goal.February 26, 2025 | Paradigm Press (Ad)Pfizer’s TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate CancerFebruary 13, 2025 | finance.yahoo.comRedHill Biopharma launches trial of combination therapy for prostate cancerFebruary 5, 2025 | finance.yahoo.comRanji Trophy: Saurashtra take first-innings lead against JharkhandNovember 9, 2024 | msn.comLadakh disengagement taking place in 'orderly' manner: ChinaOctober 30, 2024 | msn.comIndian Army’s first brush with the PLA was in 1951. The windfall was Chushul airfieldOctober 24, 2024 | msn.comSee More Headlines ARPI Stock Analysis - Frequently Asked Questions How were (ARPI)'s earnings last quarter? (ARPI) (NYSE:ARPI) issued its earnings results on Wednesday, November, 4th. The real estate investment trust reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.21 by $0.07. The company's revenue was up 36.1% on a year-over-year basis. What other stocks do shareholders of (ARPI) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (ARPI) investors own include American Homes 4 Rent (AMH), Blackstone (BX), NGL Energy Partners (NGL), Kelly Residential & Apartment Real Estate ETF (RESI), (SBY) (sby), Starwood Property Trust (STWD) and Apartment Investment and Management (AIV). Company Calendar Last Earnings11/04/2015Today2/26/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:ARPI CUSIPN/A CIK1548981 Webwww.americanresidentialproperties.com Phone+1-480-4744800FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NYSE:ARPI) was last updated on 2/26/2025 by MarketBeat.com Staff From Our PartnersA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNvidia's February 26th announcement.Something strange is happening in Silicon Valley... Microsoft, Google, and Amazon are making unusual prepar...Banyan Hill Publishing | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored(1) Elon Musk’s Final Project REVEALEDThe world’s richest man has an ace up his sleeve. You see, while everyone is talking about Elon Musk’s plan...Paradigm Press | SponsoredIgnore Fox Business’s “man who calls it all” at your perilThis is the biggest AI investment story you’ve never been told… and people who invest before March 19 could st...The Oxford Club | SponsoredDiscover the Key to a Resilient Investment PortfolioThese 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...StockEarnings | SponsoredWall St Icon: Nvidia could 10x, but THIS could 100xI've identified a small chip maker that reminds me so much of early-stage Nvidia, it stopped me in my tracks. ...InvestorPlace | SponsoredMarch 16th--America’s most important day?The stock market cycle I'll share with you helped me call the bear market of 2018... the bull market in 2020.....Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ARPI) Please log in to your account or sign up in order to add this asset to your watchlist. Share (ARPI) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.